The third day of IPWatchdog’s PTAB Masters™ 2022 featured more from former U.S. Patent and Trademark Office (USPTO) Director Andrei Iancu, as well as panels covering topics such as avoiding obviousness mistakes, appellate strategies from the Patent Trial and Appeal Board (PTAB) and other intricacies of PTAB practice from the experts. Panelists this afternoon also weighed in on today’s announcement that Justice Stephen Breyer will retire from the Supreme Court, opening the door for Biden to appoint a replacement.
Patent
- Enablement
- Fee Shifting
- Litigation
- Jump Rope Company Asks High Court to Weigh in on CAFC Approach to Collateral Estoppel for PTAB Invalidations
- Review Not Warranted: SG Tells SCOTUS to Scrap Amgen’s Case on Enablement Test for Biotech Patents
- Advocating for Ethics-Driven Regulation for Blockchain Technologies
- Other Barks & Bites for Friday, September 23: Thaler Seeks Rehearing of CAFC Decision on DABUS AI, the Solicitor General Urges SCOTUS to Deny Cert in Amgen, and FTC Orders Amazon’s Jassy and Bezos to Testify in Prime Investigation
- Exploring the CAFC’s Ridiculous Written Description Standard for Life Sciences Patents
Recent Posts
- Jump Rope Company Asks High Court to Weigh in on CAFC Approach to Collateral Estoppel for PTAB Invalidations
- Review Not Warranted: SG Tells SCOTUS to Scrap Amgen’s Case on Enablement Test for Biotech Patents
- Advocating for Ethics-Driven Regulation for Blockchain Technologies
- Other Barks & Bites for Friday, September 23: Thaler Seeks Rehearing of CAFC Decision on DABUS AI, the Solicitor General Urges SCOTUS to Deny Cert in Amgen, and FTC Orders Amazon’s Jassy and Bezos to Testify in Prime Investigation
- Exploring the CAFC’s Ridiculous Written Description Standard for Life Sciences Patents